APA (7th ed.) Citation

Rojas, L., Muñiz, S., Medina, L., Peña, J., Acevedo, F., Pinto, M. P., & Sanchez, C. (2020). Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer. PLoS ONE, 15(2), 1. https://doi.org/10.1371/journal.pone.0227961

Chicago Style (17th ed.) Citation

Rojas, Luis, Sabrina Muñiz, Lidia Medina, Jose Peña, Francisco Acevedo, Mauricio P. Pinto, and Cesar Sanchez. "Cost-minimization Analysis of Subcutaneous Versus Intravenous Trastuzumab Administration in Chilean Patients with HER2-positive Early Breast Cancer." PLoS ONE 15, no. 2 (2020): 1. https://doi.org/10.1371/journal.pone.0227961.

MLA (9th ed.) Citation

Rojas, Luis, et al. "Cost-minimization Analysis of Subcutaneous Versus Intravenous Trastuzumab Administration in Chilean Patients with HER2-positive Early Breast Cancer." PLoS ONE, vol. 15, no. 2, 2020, p. 1, https://doi.org/10.1371/journal.pone.0227961.